Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | GRM5 | P41594 | 2/20 | 0.42 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | PYGL | P06737 | 1/20 | 0.38 |
| ▸ | PYGM | P11217 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4215189 | 0.91 | GRM4 (0.52) | L3MBTL1ALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL4311423 | 0.83 | MAPT (0.47) | L3MBTL1ALDH1A1MAPTKDM4CNPC1 | |
| SCHEMBL27028359 | 0.83 | ALDH1A1 (0.53) | L3MBTL1ALDH1A1MAPTKDM4CNPC1 | |
| SCHEMBL15907862 | 0.82 | PLOD2 (0.49) | L3MBTL1ALDH1A1MAPTKDM4CNPC1 | |
| SCHEMBL12019619 | 0.81 | ALDH1A1 (0.54) | L3MBTL1ALDH1A1MAPTKDM4CNPC1 | |
| SCHEMBL21437805 | 0.81 | L3MBTL1 (0.54) | L3MBTL1ALDH1A1MAPTKDM4CNPC1 | |
| SCHEMBL27911792 | 0.81 | ALDH1A1 (0.63) | L3MBTL1ALDH1A1MAPTKDM4CNPC1 | |
| SCHEMBL6888866 | 0.81 | L3MBTL1 (0.54) | L3MBTL1ALDH1A1MAPTKDM4CNPC1 | |
| SCHEMBL17875258 | 0.81 | L3MBTL1 (0.54) | L3MBTL1ALDH1A1MAPTKDM4CNPC1 | |
| SCHEMBL6889314 | 0.81 | ALDH1A1 (0.54) | L3MBTL1ALDH1A1MAPTKDM4CNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8044013-B2 | Complex of manganese, titanium, nickel, copper, cobalt, iron and ligands | BASF SE (DE) | 2011-10-25 | — | — | US | disclosed |
| US-8044013-B2 | Complex of manganese, titanium, nickel, copper, cobalt, iron and ligands | BASF SE (DE) | 2011-10-25 | — | — | US | disclosed |
| US-8044013-B2 | Complex of manganese, titanium, nickel, copper, cobalt, iron and ligands | BASF SE (DE) | 2011-10-25 | — | — | US | disclosed |
| US-7692004-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-04-06 | — | — | US | disclosed |
| US-7692004-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-04-06 | — | — | US | disclosed |
| US-7692004-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-04-06 | — | — | US | disclosed |
| US-20090189119-A1 | Use of metal complex compounds comprising pyridine pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h202 | WIEPRECHT TORSTEN | 2009-07-30 | — | — | US | disclosed |
| US-20090189119-A1 | Use of metal complex compounds comprising pyridine pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h202 | WIEPRECHT TORSTEN | 2009-07-30 | — | — | US | disclosed |
| US-20090189119-A1 | Use of metal complex compounds comprising pyridine pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h202 | WIEPRECHT TORSTEN | 2009-07-30 | — | — | US | disclosed |
| US-20090068282-A1 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION | 2009-03-12 | — | — | US | disclosed |
| US-7161005-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-01-09 | — | — | US | disclosed |
| US-20060264633-A1 | Use of metal complex compounds as oxidation catalysts | SCHLINGLOFF GUNTHER | 2006-11-23 | — | — | US | disclosed |
| US-20060247144-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | RECKITT BENCKISER N.V. (NL) | 2006-11-02 | — | — | US | disclosed |
| EP-1694807-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | Reckitt Benckiser N.V. (NL) | 2006-08-30 | — | — | EP | disclosed |
| EP-1383857-B1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | CIBA SC HOLDING AG (CH) | 2006-05-31 | — | — | EP | disclosed |
| US-20060100123-A1 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORP. | 2006-05-11 | — | — | US | disclosed |
| EP-1521820-B1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | CIBA SC HOLDING AG (CH) | 2006-03-22 | — | — | EP | disclosed |
| US-20060019853-A1 | Use of metal complex compounds as catalysts for oxidation using molecular oxygen or air | CIBA SPECIALTY CHEMICALS CORP. | 2006-01-26 | — | — | US | disclosed |
| WO-2005061688-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | RECKITT BENCKISER N.V. (NL) | 2005-07-07 | — | — | WO | disclosed |
| US-20040142843-A1 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORP. | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264633-A1 | Use of metal complex compounds as oxidation catalysts | MICOS13, MLX, SOD1 | L3MBTL1 690/4885ALDH1A1 4648/4885MAPT 4339/4885 |
| US-20060019853-A1 | Use of metal complex compounds as catalysts for oxidation using molecular oxygen or air | COX14, MICOS13, OR10J3 | L3MBTL1 3006/4885ALDH1A1 4208/4885MAPT 4366/4885 |
| US-20090068282-A1 | Use of metal complex compounds as oxidation catalysts | MICOS13, MLX, SOD1 | L3MBTL1 580/4885ALDH1A1 4632/4885MAPT 4354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.